SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Research output: Contribution to journal › Article › peer-review
-
Iakounine, Alexandre
- School of Environmental & Natural Sciences - Professor In Enzyme Discovery and Application
Person: Academic